On behalf of EAACI, we are delighted to welcome you to Athens for the secondInternational Severe Asthma Forum (ISAF).
Despite modern treatment facilities, less than half of our patients achieve acceptable clinical control and a substantial number have severe uncontrolled disease with risk of repeated exacerbations. The ISAF 2014 meeting will continue to build upon the success of the first ISAF meeting in Gothenburg 2012, focusing on updated translational research within the area.
The general purpose of the meeting is to assemble dedicated people in the field, involving both experienced key opinion leaders and young scientists. We hope that the meeting will facilitate future collaborative work between scientists with a common interest in the field. Another aim is to use ISAF 2014 as an initiation platform for future expert work on specified areas, translating updated science into clinical practice. Some discussions will be followed-up by future research seminars as a joint collaboration between ERS and EAACI.
One ambition with ISAF 2014 is to avoid the impression of a mini-conference with lectures covering a wide range of topics within the field. Creative interaction and discussion is the key to the future of the meeting. Therefore, this year we will focus on some aspects of severe asthma, including; severe asthma exacerbations, severe asthma and innate immune defense, including fungal asthma and biomarkers and outcome measures in severe asthma.
We look forward to welcoming speakers who will travel from all over the world to share their expertise with us. We would also like to acknowledge everyone who has made topic suggestions and submitted abstracts.